Literature DB >> 3501348

Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus.

J R Batchelor1, A H Fielder, M J Walport, J David, D K Lord, N Davey, I A Dodi, P Malasit, W Wanachiwanawin, R Bernstein.   

Abstract

Susceptibility to systemic lupus erythematosus (SLE) is known to be governed by genes in the HLA region of the 6th chromosome. From previous studies it has not been possible to distinguish between the effects of null genes for the complement component C4 and HLA-DR3, because of the marked linkage disequilibrium between DR3 and a null allele of C4A (C4A QO) in caucasoid populations. We report here an immunogenetic study of 44 cases of SLE, selected because they were DR3 negative. Eighteen of the 30 Caucasoid cases (60%) had extended HLA haplotypes with a C4 null allele, compared with 22 of 60 (37%) of a control panel of 60 DR3 negative normal Caucasoid subjects. This difference is significant (chi 2 = 4.41; 0.05 greater than P greater than 0.01). Of 14 non-caucasoid patients analysed, 10 had a C4 null allele. It is concluded that the null alleles of the C4 A and B genes are themselves directly responsible for conferring susceptibility to SLE.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501348      PMCID: PMC1542102     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Primate erythrocyte-immune complex-clearing mechanism.

Authors:  J B Cornacoff; L A Hebert; W L Smead; M E VanAman; D J Birmingham; F J Waxman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

2.  Statement on the nomenclature of human C4 allotypes.

Authors:  G Mauff; C A Alper; Z Awdeh; J R Batchelor; J Bertrams; G Bruun-Petersen; R L Dawkins; P Démant; J Edwards; H Grosse-Wilde; G Hauptmann; P Klouda; L Lamm; E Mollenhauer; C Nerl; B Olaisen; G O'Neill; C Rittner; M H Roos; V Skanes; P Teisberg; L Wells
Journal:  Immunobiology       Date:  1983-03       Impact factor: 3.144

3.  Family studies of complement C4 and HLA in man.

Authors:  G Bruun-Petersen; L U Lamm; I J Sørensen; L Buskjaer; J P Mortensen
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

4.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

5.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

Authors:  J A Schifferli; P Woo; D K Peters
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

6.  Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man.

Authors:  M C Carroll; R D Campbell; R R Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus.

Authors:  J D Reveille; F C Arnett; R W Wilson; W B Bias; R H McLean
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

10.  Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man.

Authors:  Z L Awdeh; D Raum; E J Yunis; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  13 in total

Review 1.  Genetic bases of autoimmune hepatitis.

Authors:  Albert J Czaja; Derek G Doherty; Peter T Donaldson
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Selective IgA deficiency associated with glomerulonephritis and oligoarthritis.

Authors:  J P Camilleri; R H Moore; D F Griffiths; B D Williams
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

Review 3.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

4.  C4 null alleles in childhood onset systemic lupus erythematosus. Is there any relationship with renal disease?

Authors:  S Clemenceau; F Castellano; M Montes de Oca; C Kaplan; F Danon; M Levy
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

5.  Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility.

Authors:  D De Juan; J M Martín-Villa; J J Gómez-Reino; J L Vicario; A Corell; J Martínez-Laso; D Benmammar; A Arnaiz-Villena
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

6.  Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).

Authors:  B D Reilly; C Mold
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

7.  Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.

Authors:  K Hartung; M P Baur; R Coldewey; M Fricke; J R Kalden; H J Lakomek; H H Peter; D Schendel; P M Schneider; S A Seuchter
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

8.  HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus.

Authors:  E J Davies; C J Hutchings; M C Hillarby; R P Donn; R G Cooper; E M Hay; R M Bernstein; P J Holt; D M Grennan; W E Ollier
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

Review 9.  Complement and glomerulonephritis--an update.

Authors:  R H McLean
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

10.  British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.

Authors:  Chee-Seng Yee; Vernon Farewell; David A Isenberg; Anisur Rahman; Lee-Suan Teh; Bridget Griffiths; Ian N Bruce; Yasmeen Ahmad; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; David D'Cruz; Munther A Khamashta; Peter Maddison; Caroline Gordon
Journal:  Arthritis Rheum       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.